Please provide your email address to receive an email when new articles are posted on . Medtronic announced the launch of its LAA exclusion system in the U.S. after its August 2023 FDA clearance. The ...
For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...
The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...
For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...
Please provide your email address to receive an email when new articles are posted on . AF recurrence after catheter ablation was not linked to adverse outcomes, but a nonsignificant trend for worse ...
The possibility of a drug interaction between SGLT2 inhibitors and statins was not supported by rates of rhabdomyolysis in a case-control study. (JAMA Network Open) Among patients undergoing isolated ...
A liquid injected into the heart that sets like a gel could one day prevent strokes caused by atrial fibrillation, animal tests suggest.
SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results